Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers (ABMT)
Sponsor: Hunter College of City University of New York
A PHASE2 clinical study on Anxiety, this trial is completed. The trial is conducted by Hunter College of City University of New York and has accumulated 8 data snapshots since 2015. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Aug 2018 — Jan 2021 [monthly]
Completed PHASE2
Status: Recruiting → Completed · Phase: PHASE3 → PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Phase: PHASE1_PHASE2 → PHASE3
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hunter College of City University of New York
For direct contact, visit the study record on ClinicalTrials.gov .